Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-24T03:46:48.288Z Has data issue: false hasContentIssue false

Diagnostic and antimicrobial stewardship workforce challenges: A crisis in combating antimicrobial resistance

Published online by Cambridge University Press:  29 March 2023

Tristan T. Timbrook*
Affiliation:
bioMérieux, Marcy l’Etoile, France University of Utah College of Pharmacy, Salt Lake City, Utah, United States
Andrea M. Prinzi
Affiliation:
bioMérieux, Marcy l’Etoile, France
Emily S. Spivak
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States
*
Author for correspondence: Tristan T. Timbrook, PharmD, BCIDP, Director of Health Economics Outcomes Research, Global Medical Affairs, bioMérieux, 1201 S 4800 W, Salt Lake City, UT 84104. E-mail: [email protected]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

To the Editor—Lost progress in the fight against antimicrobial resistance (AMR) is a frightening reality, and challenges in maintaining the healthcare infrastructure used to address the public health threat of AMR are increasingly prevalent. Shortages and attrition among clinical microbiologists, antimicrobial stewardship pharmacists, and physicians are common, particularly with the recent healthcare system strains of the coronavirus disease 2019 (COVID-19) pandemic. Reference Leber, Peterson and Dien Bard1Reference Rech, Jones, Naseman and Beavers3 AMR was linked to 4.95 million global deaths in 2019, and the COVID-19 pandemic the following year made things dramatically worse. 4 For instance, the Centers for Disease Control and Prevention (CDC) reported a 15% increase in antimicrobial-resistant infections in hospitals in 2020. At the same time, 80% of hospitalized patients with COVID-19 received an antibiotic between March and October 2020. Additionally, the CDC noted significant increases in infections with organisms like carbapenem-resistant Acinetobacter spp, which increased by 78% in 2020. AMR has the potential to undermine modern medicine and requires substantial immediate and sustained resources and action. 5 The CDC recommends antimicrobial stewardship programs (ASPs) to combat AMR by ensuring the appropriate use of antimicrobials, and ASPs are most effective when co-led by infectious disease-trained pharmacists and physicians. 6 Additionally, microbiologists are critical stakeholders in the success of this team in ensuring the ability to accurately and rapidly diagnose infections in addition to tracking AMR. 4,6

Together, this team performs essential collaborations such as reporting antimicrobial resistance to the CDC, which is also critical to hospitals participating in the Promoting Interoperability Program by CMS Medicare as a condition of hospital participation. 7 This frontline healthcare team is the backbone of the response against AMR yet faces substantial sustainability issues.

The COVID-19 pandemic highlighted how vital diagnostic testing and microbiologists are to healthcare systems and public health. Reference Leber, Peterson and Dien Bard1 Recent survey data have demonstrated increased vacancy rates for multiple medical laboratory areas and projected medical laboratory scientist retirement rates >20% for some departments. Reference Garcia, Kundu, Kelly and Soles8 Filling vacancies was a top concern among many respondents (14.2%), exacerbated by COVID-19–related staffing challenges, inadequate salaries, the need for a heightened profile of the profession, and concerns about a lack of adequately trained staff. Reference Leber, Peterson and Dien Bard1,Reference Garcia, Kundu, Kelly and Soles8 Importantly, staffing shortages in the medical laboratory are not benign and are associated with an increased risk of medical error. Reference Leber, Peterson and Dien Bard1 Furthermore, a reduction in adequately trained staff results in limitations in the extent of testing offered, leading to discontinuation of local testing and expanded off-site testing, which contributes to delays in appropriate treatment for patients. Reference Leber, Peterson and Dien Bard1

Lack of visibility and perceived lack of upward career mobility have been cited as drivers of laboratory staff retention, which could be addressed by further engaging the laboratory in stewardship efforts. Reference Leber, Peterson and Dien Bard1 For example, developing a diagnostic stewardship test utilization committee may help prevent burnout by reducing unnecessary testing while highlighting the important role of the laboratory in stewardship initiatives. Reference VanSpronsen, Zychla, Villatoro, Yuan, Turley and Ohinmaa9 In a recent survey of laboratorians in Canada demonstrated, 55% of respondents felt that involvement in stewardship initiatives was a valuable use of their time and they have an important role to play (70.6%). However, nearly 60% of respondents expressed that lack of time is a barrier driven by limited staffing and competing priorities. Reference VanSpronsen, Zychla, Villatoro, Yuan, Turley and Ohinmaa9 Although only one-third of hospitals in the United States report efforts to optimize diagnostic testing, this is 1 of the 6 leading stewardship practices and an area ripe for multidisciplinary improvement. Reference Stenehjem, Braun and Chitavi10 In collaboration with stewardship personnel, microbiologists are responsible for guiding actions like diagnostic test selection, providing input on appropriate reporting, and following up on critical results. Optimizing existing test use and rapid diagnostic testing with adjunctive reporting algorithms can be crucial in building more sustainable and resilient healthcare systems for addressing AMR.

Like clinical laboratory scientists, chronic and pandemic-related acute issues threaten the sustainability of ASPs among pharmacists and physicians. A recent survey of ASPs reported an increase of 5 new duties related to COVID-19, whereas 18% of stewards noted less stewardship full-time equivalent (FTE) support during this period. Reference Vaughn, Dunn, Horowitz, McLaughlin and Gandhi11 Moreover, most stewards have noted less ability to perform traditional ASP activities, and 71% noted a positive screening for burnout. Reference Vaughn, Dunn, Horowitz, McLaughlin and Gandhi11 Beyond pandemic-related issues, attrition of clinical pharmacists has been noted related to a lack of ability to buy down time for nonclinical work (eg, committees, residency program director, etc), lack of capacity to produce revenue for activities, and limited career advancement opportunities. Reference Rech, Jones, Naseman and Beavers3 Similarly, supply challenges of infectious diseases physicians were highlighted in the 2020 fellowship match, where >1 in 5 US ID fellowships went unmatched. Reference Hussaini2 Reasons for this include being among the lowest-paid specialty due to revenue activities favoring procedure-based specialties, compounded by the significant financial burden of medical education, leading many to choose other specialties. These threats to recruiting and maintaining personnel with physicians and pharmacists are problematic because these leaders are critical to the success of ASPs. 6 Survey data have suggested that for each 0.5 increase in pharmacist and physician FTE, an ∼1.5× increase in the effectiveness of ASPs occurs. Reference Doernberg, Abbo and Burdette12 In contrast, lower-resourced facilities (eg, rural and smaller hospitals) have been associated with less prospective audit and feedback, optimized diagnostic testing, and measurement of antibiotic use, which may contribute to rural health inequities in AMR. Reference Stenehjem, Braun and Chitavi10 Robust and systematic investment in human resources is integral to the growth and sustainability of ASPs.

In conclusion, AMR is a critical public health issue, and the healthcare infrastructure and related policy should prioritize ensuring the support and sustainability of the ASP team as the frontline responders to AMR. As a clinical microbiologist, antimicrobial stewardship pharmacist, and infectious diseases physician, we see this as an urgent issue that must be addressed immediately to safeguard current and future progress in combating AMR.

Acknowledgments

Financial support

No financial support was provided for this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

Leber, AL, Peterson, E, Dien Bard, J. The hidden crisis in the times of COVID-19: critical shortages of medical laboratory professionals in clinical microbiology. J Clin Microbiol 2022;60:e0024122.CrossRefGoogle ScholarPubMed
Hussaini, SMQ. Dearth of infectious diseases physicians as the USA faces a global pandemic. Lancet Infect Dis 2020;20:648649.CrossRefGoogle ScholarPubMed
Rech, MA, Jones, GM, Naseman, RW, Beavers, C. Premature attrition of clinical pharmacists: call to attention, action, and potential solutions. JACCP 2022;5:689696.Google Scholar
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399:629655.CrossRefGoogle Scholar
Reframing resistance. Wellcome website. https://wellcome.org/reports/reframing-antimicrobial-resistance-antibiotic-resistance. Published 2019. Accessed March 15, 2023.Google Scholar
Core elements of hospital antibiotic stewardship programs. Centers for Disease Control and Prevention website. https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Published 2019. Accessed March 15, 2023.Google Scholar
Promoting interoperability program. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/cdaportal/datainteroperability.html. Accessed February 22, 2023.Google Scholar
Garcia, E, Kundu, I, Kelly, M, Soles, R. The American Society for Clinical Pathology 2020 vacancy survey of medical laboratories in the United States. Am J Clin Pathol 2022;157:874889.CrossRefGoogle ScholarPubMed
VanSpronsen, AD, Zychla, L, Villatoro, V, Yuan, Y, Turley, E, Ohinmaa, A. Engaging laboratory staff in stewardship: barriers experienced by medical laboratory technologists in Canada. J Appl Lab Med 2022;7:480494.CrossRefGoogle ScholarPubMed
Stenehjem, EA, Braun, BI, Chitavi, SO, et al. Use of leading practices in US hospital antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2022. doi: 10.1017/ice.2022.241.CrossRefGoogle ScholarPubMed
Vaughn, VM, Dunn, GE, Horowitz, JK, McLaughlin, ES, Gandhi, TN. Duties, resources, and burnout of antibiotic stewards during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol 2021;1:e39.CrossRefGoogle ScholarPubMed
Doernberg, SB, Abbo, LM, Burdette, SD, et al. Essential resources and strategies for antibiotic stewardship programs in the acute care setting. Clin Infect Dis 2018;67:11681174.CrossRefGoogle ScholarPubMed